These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 9670971)
1. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. Tannenbaum CS; Tubbs R; Armstrong D; Finke JH; Bukowski RM; Hamilton TA J Immunol; 1998 Jul; 161(2):927-32. PubMed ID: 9670971 [TBL] [Abstract][Full Text] [Related]
2. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. Tannenbaum CS; Wicker N; Armstrong D; Tubbs R; Finke J; Bukowski RM; Hamilton TA J Immunol; 1996 Jan; 156(2):693-9. PubMed ID: 8543822 [TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma. Bukowski RM; Rayman P; Molto L; Tannenbaum CS; Olencki T; Peereboom D; Tubbs R; McLain D; Budd GT; Griffin T; Novick A; Hamilton TA; Finke J Clin Cancer Res; 1999 Oct; 5(10):2780-9. PubMed ID: 10537342 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma. Dorsey R; Kundu N; Yang Q; Tannenbaum CS; Sun H; Hamilton TA; Fulton AM Cancer Res; 2002 May; 62(9):2606-10. PubMed ID: 11980656 [TBL] [Abstract][Full Text] [Related]
6. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. Gasperini S; Marchi M; Calzetti F; Laudanna C; Vicentini L; Olsen H; Murphy M; Liao F; Farber J; Cassatella MA J Immunol; 1999 Apr; 162(8):4928-37. PubMed ID: 10202039 [TBL] [Abstract][Full Text] [Related]
7. Expression of the chemokines IP-10 and Mig in IL-10 transduced tumors. Sun H; Kundu N; Dorsey R; Jackson MJ; Fulton AM J Immunother; 2001; 24(2):138-43. PubMed ID: 11265771 [TBL] [Abstract][Full Text] [Related]
8. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes. Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857 [TBL] [Abstract][Full Text] [Related]
9. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma. Dajotoy T; Andersson P; Bjartell A; Löfdahl CG; Tapper H; Egesten A J Leukoc Biol; 2004 Sep; 76(3):685-91. PubMed ID: 15197236 [TBL] [Abstract][Full Text] [Related]
10. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts. Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma. Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061 [TBL] [Abstract][Full Text] [Related]
12. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma. Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188 [TBL] [Abstract][Full Text] [Related]
13. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. Sauty A; Dziejman M; Taha RA; Iarossi AS; Neote K; Garcia-Zepeda EA; Hamid Q; Luster AD J Immunol; 1999 Mar; 162(6):3549-58. PubMed ID: 10092813 [TBL] [Abstract][Full Text] [Related]
14. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma. Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685 [TBL] [Abstract][Full Text] [Related]
16. Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma. Zhang R; Tian L; Chen LJ; Xiao F; Hou JM; Zhao X; Li G; Yao B; Wen YJ; Li J; Zhang L; Chen XC; Luo F; Peng F; Jiang Y; Wei YQ Gene Ther; 2006 Sep; 13(17):1263-71. PubMed ID: 16672984 [TBL] [Abstract][Full Text] [Related]
17. A novel role for neutrophils as a source of T cell-recruiting chemokines IP-10 and Mig during the DTH response to HSV-1 antigen. Molesworth-Kenyon SJ; Oakes JE; Lausch RN J Leukoc Biol; 2005 Apr; 77(4):552-9. PubMed ID: 15629884 [TBL] [Abstract][Full Text] [Related]
18. Neutralization of interleukin-2 retards the growth of mouse renal cancer. Fukuhara H; Matsumoto A; Kitamura T; Takeuchi T BJU Int; 2006 Jun; 97(6):1314-21. PubMed ID: 16686731 [TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of the MIG and IP-10 genes transferred with poly [D,L-2,4-diaminobutyric acid] on murine neuroblastoma. Tominaga M; Iwashita Y; Ohta M; Shibata K; Ishio T; Ohmori N; Goto T; Sato S; Kitano S Cancer Gene Ther; 2007 Aug; 14(8):696-705. PubMed ID: 17514193 [TBL] [Abstract][Full Text] [Related]
20. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome. Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]